Acute inhalation exposure to vaporized methamphetamine causes lung injury in mice

Inhalation Toxicology

Volumn 20, Issue 9, 2008, Pages 829-838

  Wells, Sandra M ^a   Buford, Mary C ^a   Braseth, Sarah N ^b   Hutchison, James D ^b   Holian, Andrij ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b Montana State Crime Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HISTOPATHOLOGY; LUNG INJURY; LUNG LAVAGE; LUNG TOXICITY; LUNG WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ALBUMINS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CENTRAL NERVOUS SYSTEM STIMULANTS; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; L-LACTATE DEHYDROGENASE; LUNG; LUNG DISEASES; METHAMPHETAMINE; MICE; MICE, INBRED BALB C; ORGAN SIZE; REACTIVE OXYGEN SPECIES;

MURINAE; MUS;

EID: 47749129633     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370801895121     Document Type: Article

References (51)

1. Benov, L., Sztejnberg, L., and Fridovich, I. 1998. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radical Biol. Med. 25:826-831.
2. Bloom, J. W., Kaltenborn, W. T., Paoletti, P., Camilli, A., and Lebowitz, M. D. 1987. Respiratory effects of non-tobacco cigarettes. Br. Med. J. Clin. Res. Ed. 295:1516-1518.
3. Budd, S. L., Castilho, R. F., and Nicholls, D. G. 1997. Mitochondrial membrane potential and hydroethidine-monitored superoxide generation in cultured cerebellar granule cells. FEBS Lett. 415:21-24.
4. Cadet, J. L., Sheng, P., Ali, S., Rothman, R., Carlson, E., and Epstein, C. 1994. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62:380-383.
5. Cook, C. E., Jeffcoat, A. R., Hill, J. M., Pugh, D. E., Patetta, P. K., Sadler, B. M., White, W. R., and Perez-Reyes, M. 1993. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab. Dispos. 21:717-723.
6. Davidson, C., Gow, A. J., Lee, T. H., and Ellinwood, E. H. 2001. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36:1-22.
7. Decker, T., and Lohmann-Matthes, M. L. 1988. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods 115:61-69.
8. Deng, X., Ladenheim, B., Tsao, L. I., and Cadet, J. L. 1999. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J. Neurosci. 19:10107-10115.
9. Deng, X.,Wang, Y., Chou, J., and Cadet, J. L. 2001. Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res. Mol. Brain Res. 93:64-69.
10. Downey, G. P., Dong, Q., Kruger, J., Dedhar, S., and Cherapanov, V. 1999. Regulation of neutrophil activation in acute lung injury. Chest 116:46S-54S.
11. Fink, B., Laude, K., McCann, L., Doughan, A., Harrison, D. G., and Dikalov, S. 2004. Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. Am. J. Physiol. Cell Physiol. 287:C895-902.
12. Fligiel, S. E., Roth, M. D., Kleerup, E. C., Barsky, S. H., Simmons, M. S., and Tashkin, D. P. 1997. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest 112:319-326.
13. Forrester, J. M., Steele, A. W.,Waldron, J. A., and Parsons, P. E. 1990. Crack lung: An acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am. Rev. Respir. Dis. 142:462-467.
14. Gong, H., Jr., Fligiel, S., Tashkin, D. P., and Barbers, R. G. 1987. Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am. Rev. Respir. Dis. 136:142-149.
15. Green, D. R., and Reed, J. C. 1998. Mitochondria and apoptosis. Science 281:1309-1312.
16. Grobe, A. C., Wells, S. M., Benavidez, E., Oishi, P., Azakie, A., Fineman, J. R., and Black, S. M. 2006. Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: Role of NADPH oxidase and endothelial NO synthase. Am. J. Physiol. Lung Cell. Mol. Physiol. 290:L1069-1077.
17. Haim, D. Y., Lippmann, M. L., Goldberg, S. K., and Walkenstein, M. D. 1995. The pulmonary complications of crack cocaine. A comprehensive review. Chest 107:233-240.
18. Haugen, T. S., Skjonsberg, O. H., Kahler, H., and Lyberg, T. 1999. Production of oxidants in alveolar macrophages and blood leukocytes. Eur. Respir. J. 14:1100-1105.
19. House, R. V., Thomas, P. T., and Bhargava, H. N. 1994. Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. Immunopharmacol. Immunotoxicol. 16:1-21.
20. Huang, K. L., Shaw, K. P.,Wang, D., Hsu, K., Huang, T. S., and Chen, H. I. 2002. Free radicals mediate amphetamine-induced acute pulmonary edema in isolated rat lung. Life Sci. 71:1237-1244.
21. Jayanthi, S., Deng, X., Bordelon, M., McCoy, M. T., and Cadet, J. L. 2001. Methamphetamine causes differential regulation of prodeath and anti-death Bcl-2 genes in the mouse neocortex. FASEB J. 15:1745-1752.
22. Kenyon, N. J., van der Vliet, A., Schock, B. C., Okamoto, T., McGrew, G. M., and Last, J. A. 2002. Susceptibility to ozone-induced acute lung injury in iNOS-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L540-545.
23. Kim, I., Oyler, J. M., Moolchan, E. T., Cone, E. J., and Huestis, M. A. 2004. Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Ther. Drug Monit. 26:664-672.
24. Kooy, N. W., Royall, J. A., Ischiropoulos, H., and Beckman, J. S. 1994. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radical Biol. Med. 16:149-156.
25. LaVoie, M. J., and Hastings, T. G. 1999. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19:1484-1491.
26. Lee, Y. W., Hennig, B., Yao, J., and Toborek, M. 2001. Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J. Neurosci. Res. 66:583-591.
27. Megyeri, A., Bacso, Z., Shields, A., and Eliason, J. F. 2005. Development of a stereological method to measure levels of fluoropyrimidine metabolizing enzymes in tumor sections using laser scanning cytometry. Cytometry A 64:62-71.
28. Miller, F. J., Jr., Gutterman, D. D., Rios, C. D., Heistad, D. D., and Davidson, B. L. 1998. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ. Res. 82:1298-1305.
29. Mori, T., Ito, S., Kita, T., Narita, M., Suzuki, T., Matsubayashi, K., and Sawaguchi, T. 2007. Oxidative stress in methamphetamine-induced self-injurious behavior in mice. Behav. Pharmacol. 18:239-249.
30. National Drug Intelligence Center. 2006. National drug threat assessment 2007. Washington, DC: National Drug Intelligence Center, U.S. Department of Justice.
31. National Institute on Drug Abuse. 1991. Methamphetamine abuse: Epidemiologic issues and implications. Research Monograph 115, ed. N. J. K. M. A. Miller. Washington, DC: National Institute on Drug Abuse.
32. National Institute on Drug Abuse. 2002. Research report: Methamphetamine: Abuse and addiction. Washington, DC: National Institute on Drug Abuse, National Institutes of Health.
33. National Institute on Drug Abuse. 2006. Methamphetamine abuse and addiction. Washington, DC: National Institute on Drug Abuse, National Institutes of Health.
34. Nestor, T. A., Tamamoto, W. I., Kam, T. H., and Schultz, T. 1989a. Acute pulmonary oedema caused by crystalline methamphetamine. Lancet 2:1277-1278.
35. Nestor, T. A., Tamamoto, W. I., Kam, T. H., and Schultz, T. 1989b. Crystal methamphetamine-induced acute pulmonary edema: a case report. Hawaii Med. J. 48:457-458, 460.
36. Paravicini, T. M., Gulluyan, L. M., Dusting, G. J., and Drummond, G. R. 2002. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ. Res. 91:54-61.
37. Preston, K. L., Wagner, G. C., Schuster, C. R., and Seiden, L. S. 1985. Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain. Brain Res. 338:243-248.
38. Ricaurte, G. A., and McCann, U. D. 1992. Neurotoxic amphetamine analogues: Effects in monkeys and implications for humans. Ann. NY Acad. Sci. 648:371-382.
39. Roth, M. D., Arora, A., Barsky, S. H., Kleerup, E. C., Simmons, M., and Tashkin, D. P. 1998. Airway inflammation in young marijuana and tobacco smokers. Am. J. Respir. Crit. Care Med. 157:928-937.
40. Schaiberger, P. H., Kennedy, T. C., Miller, F. C., Gal, J., and Petty, T. L. 1993. Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine. Chest 104:614-616.
41. Schwilke, E. W., Sampaio dos Santos, M. I., and Logan, B. K. 2006. Changing patterns of drug and alcohol use in fatally injured drivers in Washington State. J. Forens. Sci. 51:1191-1198.
42. Stephans, S. E., and Yamamoto, B. K. 1994. Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux. Synapse 17:203-209.
43. Susskind, H., Weber, D. A., Volkow, N. D., and Hitzemann, R. 1991. Increased lung permeability following long-term use of free-base cocaine (crack). Chest 100:903-909.
44. Tashkin, D. P., Coulson, A. H., Clark, V. A., Simmons, M., Bourque, L. B., Duann, S., Spivey, G. H., and Gong, H. 1987. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am. Rev. Respir. Dis. 135:209-216.
45. Tashkin, D. P., Khalsa, M. E., Gorelick, D., Chang, P., Simmons, M. S., Coulson, A. H., and Gong, H., Jr. 1992. Pulmonary status of habitual cocaine smokers. Am. Rev. Respir. Dis. 145:92-100.
46. Tashkin, D. P., Kleerup, E. C., Hoh, C. K., Kim, K. J., Webber, M. M., and Gil, E. 1997. Effects of 'crack' cocaine on pulmonary alveolar permeability. Chest 112:327-335.
47. Taylor, D. R., Fergusson, D. M., Milne, B. J., Horwood, L. J., Moffitt, T. E., Sears, M. R., and Poulton, R. 2002. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 97:1055-1061.
48. Taylor, D. R., Poulton, R., Moffitt, T. E., Ramankutty, P., and Sears, M. R. 2000. The respiratory effects of cannabis dependence in young adults. Addiction 95:1669-1677.
49. Yu, B. P. 1994. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74:139-162.
50. Yu, Q., Zhang, D., Walston, M., Zhang, J., Liu, Y., and Watson, R. R. 2002. Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int. Immunopharmacol. 2:951-962.
51. Zule,W. A., and Desmond, D. P. 1999. An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. Am. J. Drug Alcohol Abuse 25:1-23.